Page last updated: 2024-08-22

gold and Adenocarcinoma Of Kidney

gold has been researched along with Adenocarcinoma Of Kidney in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (72.73)24.3611
2020's3 (27.27)2.80

Authors

AuthorsStudies
Guan, C; Li, D; Liu, Y; Man, X; Xu, Y; Yang, C; Yang, D; Zhang, L; Zhang, S; Zhu, Y1
Arendowski, A; Nizioł, J; Ossolińska, A; Ossoliński, K; Ossoliński, T; Ruman, T1
Abdoon, A; El Gendy, M; Weinfeld, M1
Contel, M; Elie, BT; Pechenyy, Y; Uddin, F1
Casanovas, O; de Miguel, I; Durduran, T; Johansson, JD; Martínez-Lozano, M; Mireles, M; Morales-Dalmau, J; Quidant, R; Sanz, V; Vidal-Rosas, EE; Vilches, C1
Contel, M; Elie, BT; Hubbard, K; Layek, B; Pechenyy, Y; Prabha, S1
Hu, J; Li, W; Liu, R; Pei, Q; Shou, T; Zhang, W1
Chiew, GGY; Kannadorai, RK; Liu, Q; Luo, KQ1
Callaghan, C; Dash, S; Lee, BR; Liu, J; Maddox, M; Mandava, SH; Peralta, D; Tarr, MA1
Beech, I; Bonifay, V; Dobrowolski, Z; Nizioł, J; Ossolińska, A; Ossoliński, K; Ossoliński, T; Ruman, T; Sekuła, J; Sunner, J1
Abdel-Mageed, AB; Abshire, C; Callaghan, C; Carry, C; Datta, A; Lai, WR; Lee, BR; Liu, J; Mandava, SH; Peralta, DV; Ranjan, M; Sholl, AB; Tarr, M; Williams, KS1

Other Studies

11 other study(ies) available for gold and Adenocarcinoma Of Kidney

ArticleYear
Red Phosphorus Decorated TiO
    Small (Weinheim an der Bergstrasse, Germany), 2021, Volume: 17, Issue:30

    Topics: Carcinoma, Renal Cell; Gold; Humans; Kidney Neoplasms; Nanotubes; Phosphorus; Photochemotherapy; Photosensitizing Agents; Photothermal Therapy; Titanium

2021
Serum and urine analysis with gold nanoparticle-assisted laser desorption/ionization mass spectrometry for renal cell carcinoma metabolic biomarkers discovery.
    Advances in medical sciences, 2021, Volume: 66, Issue:2

    Topics: Biomarkers, Tumor; Carcinoma, Renal Cell; Gold; Humans; Kidney Neoplasms; Lasers; Metal Nanoparticles; Pilot Projects; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2021
Gold Nanorods are Selective Cytotoxic Agents.
    Anti-cancer agents in medicinal chemistry, 2022, Volume: 22, Issue:5

    Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Cell Line, Tumor; Cytotoxins; Female; Gold; HeLa Cells; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Mice; Nanotubes

2022
A heterometallic ruthenium-gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer.
    Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2018, Volume: 23, Issue:3

    Topics: Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Gold; Humans; Kidney Neoplasms; Neoplasm Metastasis; Neovascularization, Pathologic; Protease Inhibitors; Ruthenium Compounds

2018
Non-invasive and quantitative in vivo monitoring of gold nanoparticle concentration and tissue hemodynamics by hybrid optical spectroscopies.
    Nanoscale, 2019, Mar-21, Volume: 11, Issue:12

    Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Gold; Hemodynamics; Humans; Hyperthermia, Induced; Infrared Rays; Kidney Neoplasms; Male; Mass Spectrometry; Metal Nanoparticles; Mice; Mice, Nude; Phototherapy; Polyethylene Glycols; Transplantation, Heterologous

2019
Preclinical evaluation of an unconventional ruthenium-gold-based chemotherapeutic: RANCE-1, in clear cell renal cell carcinoma.
    Cancer medicine, 2019, Volume: 8, Issue:9

    Topics: Angiogenic Proteins; Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Gold; Humans; Kidney Neoplasms; Male; Mice; Organometallic Compounds; Ruthenium; Treatment Outcome; Xenograft Model Antitumor Assays

2019
Apoptotic effect of green synthesized gold nanoparticles from
    International journal of nanomedicine, 2019, Volume: 14

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Nucleus; Curcuma; Gene Expression Regulation, Neoplastic; Gold; Humans; Kidney Neoplasms; Metal Nanoparticles; Mitochondria; Plant Extracts; Reactive Oxygen Species; Spectroscopy, Fourier Transform Infrared

2019
Dual functions of gold nanorods as photothermal agent and autofluorescence enhancer to track cell death during plasmonic photothermal therapy.
    Cancer letters, 2015, Feb-01, Volume: 357, Issue:1

    Topics: Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; Gold; Humans; Hyperthermia, Induced; Kidney Neoplasms; Metal Nanoparticles; Models, Biological; Nanotubes; Phototherapy; Surface Plasmon Resonance; Thermography

2015
Combined Treatment of Tyrosine Kinase Inhibitor-Labeled Gold Nanorod Encapsulated Albumin With Laser Thermal Ablation in a Renal Cell Carcinoma Model.
    Journal of pharmaceutical sciences, 2016, Volume: 105, Issue:1

    Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Coumarins; Drug Compounding; Gold; Humans; Kidney Neoplasms; Lasers; Nanotubes; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Serum Albumin; Solubility; Sorafenib

2016
Surface-Transfer Mass Spectrometry Imaging of Renal Tissue on Gold Nanoparticle Enhanced Target.
    Analytical chemistry, 2016, 07-19, Volume: 88, Issue:14

    Topics: Alkanes; Amides; Biomarkers, Tumor; Carcinoma, Renal Cell; Diglycerides; Gold; Humans; Kidney; Kidney Neoplasms; Metal Nanoparticles; Sodium; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2016
Nanotechnology combined therapy: tyrosine kinase-bound gold nanorod and laser thermal ablation produce a synergistic higher treatment response of renal cell carcinoma in a murine model.
    BJU international, 2017, Volume: 119, Issue:2

    Topics: Ablation Techniques; Animals; Carcinoma, Renal Cell; Combined Modality Therapy; Disease Models, Animal; Gold; Kidney Neoplasms; Laser Therapy; Male; Mice; Mice, Nude; Nanotechnology; Nanotubes; Protein-Tyrosine Kinases; Treatment Outcome

2017